Jim LaValle of the International Peptide Society leads a session for pharmacists fielding questions on the six peptides FDA advisers backed for 503A compounding.
Recap by typeshit. Post by Instagram on Instagram.
The non-binding vote went against the FDA's own scientists, who opposed every peptide. Six of the eight new panel members run clinics that offer peptides.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
A look at how regulators are handling the surge in peptide use, from approved medicines like insulin and GLP-1 drugs to the wider market.
A new study finds GLP-1 weight loss drugs remain a leading cause of rising health insurance costs in Massachusetts.
Loading…